Aim: To develop a model for muscle fibrosis based on full-thickness muscle defects, and to evaluate the effects of implanted stromal-derived factor (SDF)-1a-loaded collagen scaffolds. Methods: Full-thickness defects 2 mm in diameter were made in the musculus soleus of 48 rats and either left alone or filled with SDF-1a-loaded collagen scaffolds. At 3, 10, 28 and 56 days postsurgery, muscles were analyzed for collagen deposition, satellite cells, myofibroblasts and macrophages. Results: A significant amount of collagen-rich fibrotic tissue was formed, which persisted over time. Increased numbers of satellite cells were present around, but not within, the wounds. Satellite cells were further upregulated in regenerating tissue when SDF-1a-loaded collagen scaffolds were implanted. The scaffolds also attracted macrophages, but collagen deposition and myofibroblast numbers were not affected. Conclusion: Persistent muscle fibrosis is induced by full-thickness defects 2 mm in diameter. SDF-1a-loaded collagen scaffolds accelerated muscle regeneration around the wounds, but did not reduce muscle fibrosis.
Skeletal muscle fibrosis: the effect of stromal-derived factor-1a-loaded collagen scaffolds Skeletal muscle tissue repairs itself by the activation of satellite cells, which are associated with the myofibers [1, 2] . Activated satellite cells migrate to the site of injury and generate myoblasts, which eventually differentiate and fuse to each other or to damaged myofibers to restore muscle structure and function [3] [4] [5] . The satellite cells also have the capacity to replenish their numbers by self-renewal for future regeneration cycles [6] [7] [8] . However, fibrosis can also occur, which prevents full functional recovery of the muscle [3, 4, 9, 10] . Many approaches have been developed to improve muscle regeneration. The application of growth factors, such as IGF-I, FGF-II, HGF, NGF or GCSF, has been demonstrated to improve muscle regeneration by inducing satellite cell proliferation and differentiation [11] [12] [13] [14] [15] . Inhibition of TGF-b can reduce the extent of fibrosis, and promotes muscle regeneration [11, 16] . The injection of cell types such as satellite cell-derived myoblasts, side population cells, muscle-derived stem cells, mesoangioblasts, pericytes and CD133 + stem cells improves muscle regeneration after muscle injury, but also in muscle diseases, such as Duchenne muscular dystrophy [8, [17] [18] [19] [20] [21] [22] . Many muscle injury models exist, such as crush injury, freeze injury, toxin-induced injury, strains, contusions, lacerations and muscle disease models, which can induce minor muscle fibrosis [3, 4, 23] . However, full-thickness defects, which result in the loss of muscle tissue and the formation of large fibrotic lesions, are not widely studied. Such a model represents muscle resection after tumor ablation or other surgical muscle traumas. It can be used to develop methods to (re)generate skeletal muscle tissue and inhibit the formation of fibrotic tissue by implantation of a regenerative scaffold. To achieve this, the addition of growth factors or cells alone is not sufficient. Tissue-engineered constructs are required to fill up the defect and provide the necessary structural cues for the satellite cells. Several studies using such scaffolds have been performed with varying results, but loading of the scaffolds with growth factors and/or cells generally improves muscle regeneration [24] [25] [26] [27] . However, the myogenic potential of satellite cells is readily lost during culture [8, 28] . Furthermore, transplanted satellite cells and myoblasts rarely survive and their migration into the muscle tissue is limited [17, 29] . Since satellite cells are the primary cells for muscle regeneration, we loaded collagen scaffolds with stromal-derived factor (SDF)-1a to attract resident satellite cells into the defect. SDF-1a is a CXC chemokine that controls processes such as trafficking and transendothelial migration of hematopoietic cells [30] . SDF-1a binds to CXCR4, which is also present on satellite cells [31] . During embryo genesis, SDF-1a regulates the migration of muscle precursor cells [32, 33] . Moreover, in adulthood, SDF-1a is expressed by myofibers and induces migration of satellite cells [34, 35] . Therefore, the aim future science group of this study was to induce muscle fibrosis with a full-thickness muscle defect, and to evaluate the effects of SDF-1a-loaded noncrosslinked collagen scaffolds.
Materials & methods
n Rats All animal experiments were approved by the Animal Experiments Committee of the Radboud University Nijmegen Medical Centre (RUNMC) in accordance with Dutch laws and regulations on animal experiments. For the experiments, 48 5-week-old male SpragueDawley rats (Janvier, Le Genest, France) were used. The rats were housed under normal laboratory conditions and fed normal rat chow and water ad libitum. Before the start of the experiments the rats had been acclimatized to the animal facility for 1 week.
n Experimental procedures At the day of surgery, the rats received 0.02 mg/kg bodyweight buprenorphine (Temgesic; Schering Plough, Brussels, Belgium) subcutaneously as an analgesic, and also for the next 2 days with a 12 h interval. Under 5% (induction) followed by 2-3% (continuation) isoflurane anesthesia (Pharmachemie BV, Haarlem, The Netherlands), the musculus soleus of the left lower limb of the rats was gently exposed. Using a 2 mm biopsy punch, a full-thickness defect was made in the center of the m. soleus. The rats were divided into two groups of 24 animals: Wounds 2 mm in diameter without a scaffold Wounds 2 mm in diameter with collagen scaffold plus SDF-1a
The collagen scaffolds were prepared with a 1% (w/v) homogenized collagen suspension with insoluble type I collagen from bovine achilles tendon (Sigma Chemical CO, St Louis, MO, USA). The collagen suspension was degassed, frozen overnight at -25°C in aluminum trays and lyophilized. Before implantation, the collagen scaffolds were sterilized by immersion in 70% EtOH for 30 min, washed three times with sterile phosphate-buffered saline (PBS), and then incubated in PBS containing 0.1% (w/v) bovine serum albumin and 2 µg/ml SDF-1a (R&D Systems, Minneapolis, MN, USA) at room temperature for 48 h. Then the scaffolds were directly implanted into the muscle defects. The fascia and skin were closed with 5-0 Polysorb and 5-0 Vicryl sutures (Johnson & Johnson, Langhorne, PA, USA), respectively. Rats were sacrificed according to the standard CO 2 /O 2 protocol at 3, 10, 28 and 56 days postsurgery (six rats per group for every time point).
n Histology The left (wound) and right (internal control) m. soleus of the rats were excised and fixed in freshly prepared 4% paraformaldehyde in PBS for 24 h, and processed for paraffin embedding. Longitudinal muscle sections (5 µm) were collected on superfrost plus slides (Menzel-Gläser, Braunschweig, Germany). For general morphology, paraffin sections were stained with hematoxiline and eosin (according to Delafield, not shown). To detect collagen fibers, the sections were stained with azocarmine G and aniline blue (AZAN) according to standard protocols.
n Immunohistochemistry Sections were deparaffinated, rehydrated, treated with 3% H 2 O 2 for 20 min to inactivate endogenous peroxidase and postfixed with 4% formaldehyde in PBS. The sections were incubated with mouse anti-a-smooth muscle actin (a-SMA, 1:1600; Sigma), mouse anti-ED1 (CD68, 1:100; Serotec, DPC, Breda, The Netherlands) and mouse anti-MyoD (1:25; DAKO, Dakopatts, Glostrup, Denmark) overnight at 4°C as described previously [36] . Paraffin sections were also incubated with mouse anti-Pax7 (1:100; Developmental Studies Hybridoma Bank, Iowa City, CA, USA), mouse anticollagen type I (1:1000; Sigma), rabbit anticollagen type III (1:1600; Chemicon International, Temecula, USA) and mouse anti-Hsp47 (1:24000). For collagen type I and Hsp47 staining, the sections were heated in citrate buffer (pH 6,0) for 10 min at 70°C, and subsequently treated with 0.075% trypsin in PBS (pH 7.4) for 15 min. For Pax7 and collagen type III staining, the sections were first heated in 0.25 mM EDTA/10 mM TRIS buffer (pH 9.0) at 100°C for 10 min. After rinsing with 0.075% glycine in PBS, all sections were preincubated with 10% normal donkey serum (Chemicon), then followed by the primary antibodies overnight at 4°C. Subsequently, the bound antibodies were visualized using the biotinylated secondary antibodies donkey-antimouse IgG (H+L; 1:500; Jackson Labs, West Grove, PA, USA) for Pax7 and collagen type I, and donkey-antirabbit IgG (H+L; 1:500; Jackson Labs) for collagen type III, and a preformed biotinylated horse radish peroxidase and avidin complex (Vector Laboratories, Burlingame, CA, USA). The sections were stained with future science group 3,3-diaminobenzidine and photographed with a Zeiss Imager together with an AxioCam MRc5 camera using AxioVision 4.6.3 software (Carl Zeiss Microimaging GmbH, Jena, Germany).
n Quantification The relative amount of collagen was analyzed on the AZAN-stained muscle sections at every time point in:
The control muscle (C) Wounded muscle without the scaffold (W)
Wounded muscle with the collagen scaffold plus SDF-1a (W + SDF-1a)
The amounts of collagen (blue) and muscle tissue (red) were analyzed in a fixed span of 0.5 cm muscle tissue containing the wound area, and quantified using QWin software (Leica Imaging Systems, Cambridge, UK). The amount of collagen was expressed as the mean area percentage ± standard deviation of the total area. The number of Pax7 + and MyoD + cells were counted in the C and in the regenerative zone (regenerating muscle tissue at the border of the 2 mm wound) of groups W and W + SDF-1a at every time point. The numbers of Pax7 + and MyoD + cells were expressed as a mean percentage ± standard deviation of the total number of cells.
n Statistics The differences in the percentages of collagenous tissue and Pax7 + cells were tested for significance using a two-way analysis of variance (ANOVA) with Holm-Sidak post-hoc ana lysis. A p-value of less than 0.05 was considered to be significant. The percentages of MyoD + cells were not normally distributed and therefore the one-way ANOVA with post-hoc Holm-Sidak ana lysis was used to test significance at individual time points. A p-value of less than 0.01 was then considered to be significant (Bonferroni correction).
Results
In the experimental group without the collagen scaffold (W) one rat died during surgery. All the other rats showed an initial growth arrest, but all had gained approximately 25% bodyweight at the tenth day postsurgery. Macroscopically, the collagen scaffolds were only visible at day 3 postsurgery and remained inside the defect.
n AZAN staining Paraffin sections were stained with AZAN to identify muscle tissue (red) and collagen (blue) ( Figure 1A ). In the C group little collagen was present. At 3 days postsurgery, the defect was still visible in the W group, and some collagen was already deposited at the borders of the defects. At 10 days, large collagen deposits were present in and around the wounds, which persisted at 28 and 56 days. In the W + SDF-1a group, the scaffolds were clearly visible and surrounded by a fibrin blood clot at 3 days. Collagen was also visible at the borders of the defects. At 10 days, the scaffold became smaller and had completely disappeared at 28 and 56 days, but extensive collagen depositions were still present in these wounds. Few regenerating myofibers are found within the collagen depositions.
Quantification of the relative amount of collagen is presented in Figure 1B . At 3 days postsurgery, the amount of collagen was significantly increased from 8.6 ± 2.9% in the C group to 26.7 ± 2.1% and 31.1 ± 1.9% in the W and W + SDF-1a groups, respectively. At 10 days, the amount of collagen in both wounds was further increased to approximately 45% and remained constant up to 56 days postsurgery. The amount of collagen between the W and W + SDF-1a groups was not significantly different at any time point. + cells are presented in Figure 2B . At 3 days, the numbers of Pax7 + cells were significantly increased from 7.8 ± 0.9% in the C group to 14.5 ± 1.2% in the W group. In the W + SDF-1a group it was further increased to 18.6 ± 1.4%. At 10 days, the numbers of Pax7 + cells were compared with the C group significantly increased to 12.7 ± 1.1% in the W group, and in the W + SDF-1a group even further to 16.7 ± 1.4%. At 28 days the numbers of Pax7 + cells were still significantly increased to approximately 11% in both the W and W + SDF-1a groups. At 56 days it had normalized to control levels in both groups. In the C group the numbers of Pax7 + cells were diminished significantly in time, and in the wounds their numbers were upregulated in the first 10 days and then gradually diminished to control levels.
future science group
In the C group only a few numbers of MyoD + cells were found, but in the W and W + SDF-1a groups many MyoD + cells and myofibers were present in the regenerative zone around the wounds. In the W and W + SDF-1a groups, the numbers of MyoD + cells seemed to have increased at 3 and 10 days and then diminished again. The quantification of the relative numbers of MyoD + cells and myofibers is presented in Figure 3B . The numbers of MyoD + cells in the C group diminished over time and were always significantly lower than in the W and W + SDF-1a groups. At 3 days postsurgery, the numbers of MyoD + cells and myofibers in the W group (14.9 ± 3.3%) and W + SDF-1a group (15.4 ± 2.2%) were not significantly future science group different. At 10 days the numbers of MyoD + cells and myofibers were significantly higher in the W + SDF-1a group (23.5 ± 2.5%) than in the W group (17.7 ± 2.8%), but at 28 days the number of MyoD + cells and myofibers was significantly lower in the W + SDF-1a group (9.9 ± 3.1%) than in the W group (18.4 ± 3.3%). At day 56 postsurgery there were no differences found between the W and W + SDF-1a groups.
n Collagen I & III immunostaining Paraffin sections were stained with antibodies against collagen I and III (Figure 4) . In the C group collagen I expression was only found near blood vessels. In time, the expression pattern of collagen I was not different between the W and W + SDF-1a groups. At 3 days postsurgery there is no expression of collagen I around the wounds in both the W and W + SDF-1a groups. At 10 days collagen I is expressed around the wounds in both groups. At these time points, the collagen scaffold was also positive for collagen I. At 28 and 56 days more collagen I was expressed and bundles of collagen were formed, but the expression varies within the wounds in both groups.
In the C group collagen III was only expressed around blood vessels. Between the W and W + SDF-1a groups no differences were found in collagen III expression. At 3 days postsurgery collagen III was expressed around the wounds in the W and W + SDF-1a groups. In time, the expression of collagen III diminished in both groups. n a-SMA & ED1 immunostaining Sections were also stained with antibodies against a-SMA to identify myofibroblasts and blood vessels, and ED1 to identify macrophages ( Figure 5 ). In the C group only a-SMA + blood vessels were found. In both the W and W + SDF-1a-groups the expression pattern of a-SMA was similar over time. At 3 days a-SMA + myofibroblasts are found around the wounds in the W and W + SDF-1a groups. Inside the scaffold, a-SMA expression is absent. At 10 days the wound in the W group is filled with a-SMA + myofibroblasts. In the W + SDF-1a group, the scaffold is surrounded by a-SMA + myofibroblasts. Within the scaffolds some a-SMA + blood vessels were also found. At 28 days the wounds in both groups still contained a-SMA + myofibroblasts, which were diminished after 56 days.
Only a small number of ED1 + cells are found in the C group. In both the W and W + SDF1a groups, the tissue around the wounds was infiltrated by many ED1 + cells at 3 days. In the W + SDF-1a group, more ED1 + cells had infiltrated the tissue around and inside the scaffold. At 10 days the numbers of ED1 + cells were greatly reduced in the tissue around the wounds in both groups. The scaffold itself was still completely filled with ED1 + cells. At 28 and 56 days the numbers of ED1 + cells had decreased further and appeared equal in the W and W + SDF-1a groups.
discussion
Full-thickness defects in the m. soleus impair muscle regeneration. Histology showed that regenerating fibers are present at the border of the defects, and only small numbers of regenerating myofibers are present within the defect, but these do not cross the wound. The defect is replaced by fibrotic tissue at 10 days, which persists for up to 56 days, and it is unlikely that complete regeneration of the m. soleus will occur. We assume that the function of these muscles will be severely impaired, although this was not studied. It has recently been reported 
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future science group that large defects in the musculus gastrocnemius also show impaired regeneration and significant loss of function [37] . Therefore, the full-thickness wound model presented here provides a solid basis to develop tissue engineering therapies to improve muscle regeneration, prevent fibrosis and restore muscle function. Nevertheless, future studies should also include functional testing. Tissue engineering is a powerful and promising strategy to repair full-thickness tissue defects [25] [26] [27] . The constructs should provide future science group the necessary cues for the cells to regenerate the muscle tissue. In this study, SDF-1a-loaded collagen scaffolds were used for the first time to attract resident satellite cells to induce muscle regeneration. It has been previously demonstrated that only part of the SDF-1a is released from the scaffold in vitro in time [38] . Therefore, SDF-1a is probably gradually released into the muscle tissue and provides a migratory gradient for satellite cells directed towards the defect. Although SDF-1a has the potential to attract satellite cells by binding to the CXCR4 receptor [34, 35] , these cells are absent within the scaffold, and regeneration of the defect does not occur. By contrast, during the first 10 days, the number of satellite cells, myoblasts and myofibers were significantly increased in the regenerative zone around the SDF-1a-loaded collagen scaffolds. At 28 days the number of satellite cells was equal in the W and W + SDF-1a groups. However, the number of MyoD + myoblasts and myofibers decreased. Therefore, it is likely that SDF-1a creates an influx of satellite cells towards the regenerative zone in the first few days, which will produce MyoD + myoblasts and myotubes over time, and thereby accelerate muscle regeneration around the scaffolds. According to myogenin expression, these satellite cells and myoblasts do not migrate into the scaffold to form new myofibers. This indicates that internal muscle regeneration does not occur. Since we found many other cells and also blood vessels inside the scaffold, it remains unclear why the satellite cells did not migrate into the scaffold. Collagen type I might not be a suitable substrate for satellite cells [39] .
Implanting SDF-1a-loaded collagen scaffolds also created a larger influx of macrophages around and inside the scaffolds. It is possible future science group that the collagen scaffold exerts an immune response, but immune cells also express CXCR4 [40] , which could also explain this. It has been shown that macrophages and monocytes play a crucial role in muscle regeneration [41] [42] [43] .
Macrophages secrete soluble factors regulating satellite cell activity, and protect the satellite cells from apoptosis through cell-cell contact [44] . In the initial inflammatory phase of muscle regeneration, M1 (early) macrophages are present, which stimulate the proliferation of satellite cells. Later, M2 (late) macrophages appear and stimulate the differentiation of satellite cells [45] . Therefore, the influx of macrophages might be beneficial for muscle regeneration. It is possible that macrophages are attracted by the collagen scaffold itself, and induce the increase of Pax7 + cells, MyoD + cells and myotubes in the regenerative zone. However, in a previous laceration wound model, we implanted an empty crosslinked collagen scaffold, which induced a similar inflammatory response and influx of macrophages [36] . This did not increase the number of Pax7 + cells (Figure 6 ). Therefore, we conclude that the increased influx of Pax7 + cells, MyoD + cells and myotubes in the regenerative zone is a specific effect of the SDF-1a.
Furthermore, macrophages are probably responsible for the degradation of the collagen scaffold. This is necessary before the defect can be replaced with functional muscle tissue. However, in this study the SDF-1a-loaded collagen scaffold seems to be replaced by de novo collagen deposition, as in the W group. In the first few days collagen III is predominantly expressed, which diminished over time. By contrast, collagen I deposition is increased over time. The same results have also been found in other studies [46, 47] . However, the expression of collagen I varies within the wound, and is not as strong as in skin wounds [Grefte s et al. Unpublished Data] .
Myofibroblasts, generally identified by the expression of a-SMA, produce large amounts of collagen, and play an important role in fibrosis [48] . They rapidly appear in both wound groups, and persist up to 56 days. However, it has been shown that myoblasts can also express a-SMA [49] . The fibrotic areas are also positive for Hsp47 (Figure 7) , which is related to collagen production in (myo)fibroblasts, and thus further identifies these cells [50] . Unfortunately, myoblasts and regenerating myofibers can also express Hsp47 [51] . The fact that all a-SMA + and Hsp47 + cells do not show Pax7, MyoD and myogenin staining (Figure 7) indicates that the vast majority of these cells are myofibroblasts and not myoblasts. The expression pattern of a-SMA and Hsp47 is also mirrored by collagen type I and III expression, which confirms the role of myofibroblasts in muscle fibrosis. In both groups, the area of myofibroblasts and collagen expands outside the defect. Factors from the wound might attract myofibroblasts into the surrounding muscle tissue, which produce collagen and enlarge the future science group fibrotic area. The remodeling of the fibrotic tissue seems to go on up to 56 days as myofibroblasts are still present. Within the scaffold a-SMA + blood vessels are also present indicating that they are well-vascularized and support cell survival. In order to reduce the formation of fibrotic tissue, other scaffolds could be used. It is possible that collagen type I scaffolds trigger degradation and replacement with de novo collagen. Other scaffolds, such as alginate hydrogels, fibrin gels and synthetic scaffolds, could be used [25, 27, 52] . Furthermore, the incorporation of antifibrotic components in the scaffold might further inhibit the formation of fibrotic tissue. Decorin is a proteoglycan that can bind TGF-b, which plays a major role in tissue fibrosis [53] . Several studies show that decorin reduces fibrosis, leading to improved functional muscle regeneration [11, 16] . However, in these studies, decorin was injected into lacerated muscle, but no studies have been performed on the implantation of scaffolds loaded with decorin into full-thickness muscle defects. Additional growth factors, such as SDF-1a, HGF, IGF-I, FGF-II and NGF, or granulocyte colony-stimulating factor, can be incorporated into the scaffold. This type of approach might be promising to induce functional muscle regeneration in full-thickness muscle defects.
Conclusion
Taken together, these data show that full-thickness defects impair muscle regeneration leading to muscle fibrosis. This model can be used to study therapeutic modalities to improve muscle regeneration. Implantation of an SDF-1a-loaded collagen scaffold into the defect increases the number of Pax7 + satellite cells, and MyoD Adapted with permission from [36] .
Hsp47
Pax7 MyoD MyoG α-SMA around, but not within, the scaffolds. In time, the scaffold is replaced by fibrotic tissue. Future experiments should focus on growth factorloaded scaffolds to accelerate muscle regeneration in combination with antifibrotic components to inhibit the formation of fibrotic tissue. 
executive summary
Functional muscle regeneration is often incomplete due to the formation of fibrotic tissue. Full-thickness muscle defects are good models to induce muscle fibrosis, but are not extensively studied. Tissue-engineered constructs may have the potential to regenerate full-thickness defects in skeletal muscle. Full-thickness defects 2 mm in diameter in the musculus soleus induce local Pax7, MyoD, ED1 and a-smooth muscle actin expression, but eventually resulted in the formation of fibrotic tissue. Application of stromal-derived factor-1a-loaded collagen scaffolds into full-thickness defects induced an increased influx of activated satellite cells into the regenerative zone and seemed to accelerate muscle regeneration. Application of stromal-derived factor-1a-loaded collagen scaffolds into full-thickness defects had no effect on collagen I, collagen III and a-smooth muscle actin expression, and did not prevent the formation of fibrotic tissue. To improve functional muscle regeneration in full-thickness defects, implanted scaffolds need to be loaded with satellite cell attractants combined with antifibrotic components.
